MedTrace Logo

Comparison Levobupivacaine and Ropivacaine for TAP-block After Caesarean Section

NCT03302689 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2017-10-25

No results posted yet for this study

Summary

Randomized, double-blind, controlled trial: a comparison of Levobupivacaine and Ropivacaine for postoperative analgesia using TAP-block

Objectives:

1. VAS score during the first 12 hours
2. Determine which drug is more effective for postoperative analgesia in the first 12 hours after surgery
3. Side effects

Conditions

  • Pain, Postoperative

Interventions

DRUG

Levobupivacaine Solution

TAP-block with Levobupivacaine 0,3% - 25 ml from each side

DRUG

Ropivacaine Solution

TAP-block with Ropivacaine 0,3% - 25 ml from each side

Sponsors & Collaborators

  • Alexandr Ronenson

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-25
Primary Completion
2017-10-23
Completion
2018-01-01

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03302689 on ClinicalTrials.gov